Is it possible that the EMA would expedite their approval process for Anavex since the United States has approved Leqembi?
Seems to me that the EMA has already demonstrated their willingness to find a safe AD drug by accepting our small P2b/3 trial (n= 509) as opposed to the typical double P3 trial.